Notice: This company has been marked as potentially delisted and may not be actively trading. Alimera Sciences (ALIM) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ANI Pharmaceuticals’ Record Growth and Strategic AcquisitionNovember 9, 2024 | markets.businessinsider.comAlimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.comStockNews.com started coverage on Alimera Sciences in a research report on Sunday. They issued a "hold" rating for the company.September 22, 2024 | marketbeat.comANI Pharmaceuticals’ Acquisition of Alimera Sciences Bolsters Buy Rating and $94 Target PriceSeptember 18, 2024 | markets.businessinsider.comAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest UpdateAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 578,500 shares, a decrease of 13.8% from the August 15th total of 670,900 shares. Based on an average trading volume of 846,400 shares, the short-interest ratio is presently 0.7 days.September 16, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?September 12, 2024 | finance.yahoo.comAlimera Sciences, Inc. (ALIM)September 11, 2024 | finance.yahoo.comAlimera Sciences: Deal Closing After All, CVR Still AttractiveSeptember 11, 2024 | seekingalpha.comANI Pharmaceuticals, Alimera Sciences deal set to close MondaySeptember 11, 2024 | msn.comAlimera Sciences Shares Slide on Merger LawsuitSeptember 10, 2024 | marketwatch.comAlimera Files Lawsuit Against ANI To Enforce Merger Deal, Stock Down Nearly 19%September 10, 2024 | markets.businessinsider.comAlimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger AgreementSeptember 10, 2024 | finance.yahoo.comANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera SciencesSeptember 10, 2024 | finance.yahoo.comAlimera Sciences plunges after it sues ANI Pharmaceuticals to close dealSeptember 10, 2024 | msn.comAlimera Sciences (NASDAQ:ALIM) Coverage Initiated at StockNews.comStockNews.com assumed coverage on Alimera Sciences in a research report on Thursday. They issued a "hold" rating on the stock.August 29, 2024 | marketbeat.comALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera ...August 20, 2024 | businesswire.comVanguard Group Inc. Grows Stake in Alimera Sciences, Inc. (NASDAQ:ALIM)Vanguard Group Inc. grew its holdings in shares of Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) by 61.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,045,460 shares of the biopharmaceutical company's stock after buying an additional 396,5August 19, 2024 | marketbeat.comDeltec Asset Management LLC Invests $690,000 in Alimera Sciences, Inc. (NASDAQ:ALIM)Deltec Asset Management LLC acquired a new position in Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 124,169 shares of the biopharmaceutical company's stock, valued aAugust 14, 2024 | marketbeat.comShould You Invest on Alimera Sciences, Inc. (ALIM) Right Now?August 9, 2024 | msn.comAlimera Sciences (NASDAQ:ALIM) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSAlimera Sciences (NASDAQ:ALIM - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The firm had revenue of $27.00 million during the quarter, compared to analyst estimates of $25.76 million. Alimera Sciences had a negative net margin of 23.74% and a negative return on equity of 53.49%.August 7, 2024 | marketbeat.comAlimera Sciences Reports Second Quarter 2024 ResultsAugust 6, 2024 | globenewswire.comALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.July 27, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJuly 26, 2024 | prnewswire.comInvesting in Alimera Sciences (NASDAQ:ALIM) a year ago would have delivered you a 68% gainJuly 25, 2024 | finance.yahoo.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Increase in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 617,100 shares, a growth of 169.1% from the June 30th total of 229,300 shares. Based on an average daily volume of 324,600 shares, the short-interest ratio is presently 1.9 days.July 25, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Up 142.1% in JuneAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 229,300 shares, an increase of 142.1% from the June 15th total of 94,700 shares. Based on an average trading volume of 312,200 shares, the short-interest ratio is presently 0.7 days.July 12, 2024 | marketbeat.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIMJuly 3, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJuly 2, 2024 | prnewswire.comAlimera Sciences' (ALIM) Neutral Rating Reaffirmed at Alliance Global PartnersAlliance Global Partners restated a "neutral" rating on shares of Alimera Sciences in a research report on Tuesday.June 25, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by HC Wainwright to NeutralHC Wainwright lowered Alimera Sciences from a "buy" rating to a "neutral" rating in a research report on Tuesday.June 25, 2024 | marketbeat.comShareholder Alert: Ademi LLP investigates whether Alimera Sciences, Inc. has obtained a Fair Price for its Public ShareholdersJune 24, 2024 | prnewswire.comWhy Is Alimera Sciences (ALIM) Stock Up 77% Today?June 24, 2024 | investorplace.comALIM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Alimera Sciences to ANI PharmaceuticalsJune 24, 2024 | globenewswire.comALIM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to ShareholdersJune 24, 2024 | businesswire.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Significant Growth in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 127,000 shares, a growth of 22.2% from the May 15th total of 103,900 shares. Based on an average trading volume of 98,200 shares, the days-to-cover ratio is presently 1.3 days.June 15, 2024 | marketbeat.comAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 4, 2024 | globenewswire.comHC Wainwright Research Analysts Cut Earnings Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM)Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) - Analysts at HC Wainwright decreased their Q3 2024 earnings estimates for Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will post earnings per share of (May 17, 2024 | marketbeat.comRobust Growth and Promising Trials: Buy Rating for Alimera SciencesMay 16, 2024 | markets.businessinsider.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $6.00 price target on shares of Alimera Sciences in a report on Thursday.May 16, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Issues Earnings Results, Misses Estimates By $0.08 EPSAlimera Sciences (NASDAQ:ALIM - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.08). The business had revenue of $23.01 million during the quarter, compared to analyst estimates of $23.72 million. Alimera Sciences had a negative net margin of 24.93% and a negative return on equity of 130.90%. During the same period in the previous year, the firm posted ($0.71) EPS.May 15, 2024 | marketbeat.comAlimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...May 15, 2024 | finance.yahoo.comAlimera Sciences Reports First Quarter 2024 ResultsMay 14, 2024 | globenewswire.comAlimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress ConferencesMay 7, 2024 | finance.yahoo.comAlimera Sciences (ALIM) to Release Earnings on TuesdayAlimera Sciences (NASDAQ:ALIM) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591841)May 7, 2024 | marketbeat.comAlimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateApril 30, 2024 | finance.yahoo.comStockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to HoldStockNews.com cut Alimera Sciences from a "buy" rating to a "hold" rating in a report on Tuesday.April 30, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Alimera Sciences from a "hold" rating to a "buy" rating in a research report on Monday.April 22, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Growth in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 108,800 shares, a growth of 26.8% from the March 15th total of 85,800 shares. Based on an average daily volume of 81,900 shares, the days-to-cover ratio is presently 1.3 days.April 13, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to "Hold"StockNews.com lowered shares of Alimera Sciences from a "buy" rating to a "hold" rating in a report on Friday.April 12, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Lifted to Buy at StockNews.comStockNews.com upgraded shares of Alimera Sciences from a "hold" rating to a "buy" rating in a research note on Thursday.April 4, 2024 | marketbeat.comLuckie & Company Acquires Marbury Creative GroupApril 3, 2024 | finance.yahoo.com Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol ALIM Media Mentions By Week ALIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALIM News Sentiment▼0.000.60▲Average Medical News Sentiment ALIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALIM Articles This Week▼01▲ALIM Articles Average Week Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RCKT News Today BCYC News Today AVDL News Today COLL News Today SEPN News Today BCAX News Today ZYME News Today GYRE News Today PSTX News Today PAHC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALIM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
